The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
暂无分享,去创建一个
[1] Jian-Hua Liu,et al. A novel tigecycline resistance gene, tet(X6), on an SXT/R391 integrative and conjugative element in a Proteus genomospecies 6 isolate of retail meat origin. , 2020, The Journal of antimicrobial chemotherapy.
[2] E. Viedma,et al. Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence , 2019, Antimicrobial Agents and Chemotherapy.
[3] Jianzhong Shen,et al. Novel Plasmid-Mediated tet(X5) Gene Conferring Resistance to Tigecycline, Eravacycline, and Omadacycline in a Clinical Acinetobacter baumannii Isolate , 2019, Antimicrobial Agents and Chemotherapy.
[4] Suzanne M. Paley,et al. The BioCyc collection of microbial genomes and metabolic pathways , 2019, Briefings Bioinform..
[5] G. Wang,et al. Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans , 2019, Nature Microbiology.
[6] Jian Sun,et al. Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli , 2019, Nature Microbiology.
[7] Yonghong Xiao,et al. Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii , 2019, Antimicrobial Resistance & Infection Control.
[8] Samuel I. Miller,et al. Inhibiting the Evolution of Antibiotic Resistance , 2019, Molecular cell.
[9] Eric D. Kelsic,et al. Spatiotemporal microbial evolution on antibiotic landscapes , 2016, Science.
[10] S. Kazmirski,et al. Resistance mutations generate divergent antibiotic susceptibility profiles against translation inhibitors , 2016, Proceedings of the National Academy of Sciences.
[11] E. Nudler,et al. ppGpp couples transcription to DNA repair in E. coli , 2016, Science.
[12] Karl A. Hassan,et al. Rapid multiplexed phenotypic screening identifies drug resistance functions for three novel efflux pumps in Acinetobacter baumannii. , 2016, The Journal of antimicrobial chemotherapy.
[13] Minjun Yang,et al. Sensor histidine kinase is a β-lactam receptor and induces resistance to β-lactam antibiotics , 2016, Proceedings of the National Academy of Sciences.
[14] Peter D. Karp,et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases , 2015, Nucleic Acids Res..
[15] Deletions in a ribosomal protein-coding gene are associated with tigecycline resistance in Enterococcus faecium. , 2015, International journal of antimicrobial agents.
[16] H. Gingras,et al. Induced tigecycline resistance in Streptococcus pneumoniae mutants reveals mutations in ribosomal proteins and rRNA. , 2015, The Journal of antimicrobial chemotherapy.
[17] Y. Shamoo,et al. Acinetobacter baumannii Repeatedly Evolves a Hypermutator Phenotype in Response to Tigecycline That Effectively Surveys Evolutionary Trajectories to Resistance , 2015, PloS one.
[18] Sacha A. F. T. van Hijum,et al. CiVi: circular genome visualization with unique features to analyze sequence elements , 2015, Bioinform..
[19] Ahmad S. Khalil,et al. Antibiotic efficacy is linked to bacterial cellular respiration. , 2015, Proceedings of the National Academy of Sciences of the United States of America.
[20] Y. Shamoo,et al. The Ribosomal S10 Protein Is a General Target for Decreased Tigecycline Susceptibility , 2015, Antimicrobial Agents and Chemotherapy.
[21] M. Blokesch,et al. The type VI secretion system of Vibrio cholerae fosters horizontal gene transfer , 2015, Science.
[22] Xi Li,et al. Global transcriptional response of Acinetobacter baumannii to a subinhibitory concentration of tigecycline. , 2014, International journal of antimicrobial agents.
[23] Ming-Chin Chan,et al. AdeRS combination codes differentiate the response to efflux pump inhibitors in tigecycline-resistant isolates of extensively drug-resistant Acinetobacter baumannii , 2014, European Journal of Clinical Microbiology & Infectious Diseases.
[24] S. Solomon,et al. Antibiotic resistance threats in the United States: stepping back from the brink. , 2014, American family physician.
[25] Xuan-xian Peng,et al. Fluctuation of multiple metabolic pathways is required for Escherichia coli in response to chlortetracycline stress. , 2014, Molecular bioSystems.
[26] B. Ueberheide,et al. UvrD facilitates DNA repair by pulling RNA polymerase backwards , 2014, Nature.
[27] M. Hamidian,et al. Tn6168, a transposon carrying an ISAba1-activated ampC gene and conferring cephalosporin resistance in Acinetobacter baumannii. , 2014, The Journal of antimicrobial chemotherapy.
[28] Daniel S. Terry,et al. Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis , 2013, Proceedings of the National Academy of Sciences.
[29] Steven L. Salzberg,et al. EDGE-pro: Estimated Degree of Gene Expression in Prokaryotic Genomes , 2013, Evolutionary bioinformatics online.
[30] M. Hamidian,et al. Tn 6168 , a transposon carrying an ISAba 1-activated ampC gene and conferring cephalosporin resistance in Acinetobacter baumannii , 2013 .
[31] M. Bassetti,et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] Donoghue,et al. Acinetobacter baumannii , 2012, Virulence.
[33] J. Herrou,et al. Molecular Structure and Function of the Novel BrnT/BrnA Toxin-Antitoxin System of Brucella abortus* , 2012, The Journal of Biological Chemistry.
[34] Karl A. Hassan,et al. Adherence and motility characteristics of clinical Acinetobacter baumannii isolates. , 2011, FEMS microbiology letters.
[35] S. Shuman,et al. RtcB, a Novel RNA Ligase, Can Catalyze tRNA Splicing and HAC1 mRNA Splicing in Vivo* , 2011, The Journal of Biological Chemistry.
[36] N. Loman,et al. Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy. , 2011, The Journal of antimicrobial chemotherapy.
[37] Karl A. Hassan,et al. Roles of DHA2 Family Transporters in Drug Resistance and Iron Homeostasis in Acinetobacter spp. , 2011, Journal of Molecular Microbiology and Biotechnology.
[38] S. Shuman,et al. RtcB Is the RNA Ligase Component of an Escherichia coli RNA Repair Operon* , 2011, The Journal of Biological Chemistry.
[39] You-ning Liu,et al. Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious Disease , 2010, Antimicrobial Agents and Chemotherapy.
[40] L. Garcia. Synergism Testing: Broth Microdilution Checkerboard and Broth Macrodilution Methods , 2010 .
[41] L. Garcia. Clinical Microbiology Procedures Handbook, 3rd Edition , 2010 .
[42] Daniel N. Wilson. The A–Z of bacterial translation inhibitors , 2009, Critical reviews in biochemistry and molecular biology.
[43] J. Vila,et al. CraA, a Major Facilitator Superfamily Efflux Pump Associated with Chloramphenicol Resistance in Acinetobacter baumannii , 2009, Antimicrobial Agents and Chemotherapy.
[44] George A. Jacoby,et al. AmpC β-Lactamases , 2009, Clinical Microbiology Reviews.
[45] Harald Seifert,et al. Acinetobacter baumannii: Emergence of a Successful Pathogen , 2008, Clinical Microbiology Reviews.
[46] D. Linkin,et al. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[47] S. Magnet,et al. AdeIJK, a Resistance-Nodulation-Cell Division Pump Effluxing Multiple Antibiotics in Acinetobacter baumannii , 2008, Antimicrobial Agents and Chemotherapy.
[48] Edie M. Scheurwater,et al. Lytic transglycosylases: bacterial space-making autolysins. , 2008, The international journal of biochemistry & cell biology.
[49] J. Collins,et al. A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics , 2007, Cell.
[50] J. Schafer,et al. Early Experience with Tigecycline for Ventilator‐Associated Pneumonia and Bacteremia Caused by Multidrug‐Resistant Acinetobacter baumannii , 2007, Pharmacotherapy.
[51] D. Paterson,et al. Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii , 2007, Antimicrobial Agents and Chemotherapy.
[52] Y. Carmeli,et al. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. , 2007, The Journal of antimicrobial chemotherapy.
[53] F. Baquero,et al. Antibiotic Coresistance in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae and In Vitro Activity of Tigecycline , 2006, Antimicrobial Agents and Chemotherapy.
[54] L. Piddock. Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria , 2006, Clinical Microbiology Reviews.
[55] D. Hughes,et al. Tigecycline is modified by the flavin-dependent monooxygenase TetX. , 2005, Biochemistry.
[56] P. Bradford,et al. A Novel MATE Family Efflux Pump Contributes to the Reduced Susceptibility of Laboratory-Derived Staphylococcus aureus Mutants to Tigecycline , 2005, Antimicrobial Agents and Chemotherapy.
[57] A. Yamaguchi,et al. Effects of Efflux Transporter Genes on Susceptibility of Escherichia coli to Tigecycline (GAR-936) , 2004, Antimicrobial Agents and Chemotherapy.
[58] F. Odds,et al. Synergy, antagonism, and what the chequerboard puts between them. , 2003, The Journal of antimicrobial chemotherapy.
[59] R. Gourse,et al. Control of rRNA expression by small molecules is dynamic and nonredundant. , 2003, Molecular cell.
[60] C. Dean,et al. Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1 , 2003, Antimicrobial Agents and Chemotherapy.
[61] P. Bradford,et al. AcrAB Multidrug Efflux Pump Is Associated with Reduced Levels of Susceptibility to Tigecycline (GAR-936) in Proteus mirabilis , 2003, Antimicrobial Agents and Chemotherapy.
[62] Wai-Leung Ng,et al. Transcriptional Regulation and Signature Patterns Revealed by Microarray Analyses of Streptococcus pneumoniae R6 Challenged with Sublethal Concentrations of Translation Inhibitors , 2003, Journal of bacteriology.
[63] Daniel N. Wilson,et al. Dissection of the mechanism for the stringent factor RelA. , 2002, Molecular cell.
[64] A Kornberg,et al. Role of Inorganic Polyphosphate in Promoting Ribosomal Protein Degradation by the Lon Protease in E. coli , 2001, Science.
[65] C. Gray,et al. Mechanism‐related changes in the gene transcription and protein synthesis patterns of Haemophilus influenzae after treatment with transcriptional and translational inhibitors , 2001 .
[66] N. Jacobus,et al. In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9-t-Butylglycylamido Derivative of Minocycline (GAR-936) , 1999, Antimicrobial Agents and Chemotherapy.
[67] J. Frère,et al. Cytosolic Intermediates for Cell Wall Biosynthesis and Degradation Control Inducible β-Lactam Resistance in Gram-Negative Bacteria , 1997, Cell.
[68] M. Ammirati,et al. Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection , 1996, Antimicrobial agents and chemotherapy.
[69] S. Normark,et al. Bacterial cell wall recycling provides cytosolic muropeptides as effectors for beta‐lactamase induction. , 1994, The EMBO journal.
[70] F. Neidhardt,et al. Ribosomes as sensors of heat and cold shock in Escherichia coli. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[71] K. Cantor. Control of Macromolecular Synthesis , 1966, The Yale Journal of Biology and Medicine.
[72] O. Maaløe,et al. Control of macromolecular synthesis : a study of DNA, RNA, and protein synthesis in bacteria , 1966 .